HS-10342

· Jiangsu Hansoh Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HS-10342, covering 2021-09-16 to 2021-09-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HS-10342 in Chinese Patients With HR+/HER2- Advanced and/or Metastatic Breast Cancer [Phase 2]